Health care providers certain health care provider reimbursement arrangements disclosure to enrollees and health care providers requirement provision, Ombudsperson for public managed health care programs duties modifications, and health carrier liability when a health care provider is limited in providing services by the health carrier
SF1107 would require health plan companies, health care network cooperatives, providers, and other payers using value-based payment to disclose, during open enrollment, at enrollment, and annually thereafter, the general nature of their provider reimbursement methods. The required disclosure must explain whether payment arrangements create financial incentives for providers to limit or restrict care, including arrangements based on volume, referrals, total cost of care, risk/gain sharing, or provider tiering. Enrollees could also request more specific information about incentive plans, financial risk transfer, and other reimbursement features, and the disclosure must be available in multiple languages and approved by the commissioner before use.
The bill also expands contract disclosure obligations between health plan companies and providers. Before a provider signs a contract, the health plan company must provide the full proposed contract and related materials, plus information about fee schedules and any reimbursement-related contract conditions that may limit or restrict care. These disclosures are expressly not treated as proprietary or trade secret information. In addition, the bill creates a new cause of action making a health carrier liable for patient injury caused by delayed or denied care when that delay or denial resulted from a service limit tied to the carrier’s compensation arrangement with the provider.
The bill’s impact on state law is to add new transparency requirements in Minnesota’s health insurance and provider contracting statutes and to create a new liability provision in chapter 604. It would affect health carriers, health plan companies, providers, enrollees, and employers by increasing disclosure obligations and potentially exposing carriers to damages claims when reimbursement structures contribute to care delays or denials. The bill also sets effective dates of January 1, 2025, for the disclosure provisions and August 1, 2025, for the liability provision.
Because there are no committee transcripts or recorded votes in the provided material, the general sentiment cannot be measured from debate or roll calls. Based on the bill text alone, the measure appears aimed at consumer and provider transparency and accountability, suggesting a policy rationale focused on informed choice and patient protection. The main point of contention likely would be the new liability exposure for carriers and the breadth of required disclosure, especially where insurers and providers may view reimbursement details as commercially sensitive even though the bill states they are not proprietary.
Notable issues include whether the disclosure requirements are sufficiently clear and administrable, how multilingual and commissioner-approved notices would be implemented, and whether the liability standard could lead to litigation over causation between reimbursement limits and patient harm. The bill also appears to intersect with managed care, value-based payment, provider tiering, and insurance contract confidentiality concerns.
SF1107 would amend Minnesota Statutes sections 62J.72 and 62Q.735 and add a new section in chapter 604 establishing carrier liability for injuries caused by delayed or denied care linked to reimbursement-based service limits. It would require broader disclosure of provider payment arrangements to enrollees and providers, mandate commissioner review of certain disclosure statements, and declare those disclosures nonproprietary. The bill would therefore increase transparency obligations for health carriers and health plan companies while creating a new legal remedy for patients affected by restrictive compensation structures.
No committee discussion or vote history was provided, so there is no recorded legislative sentiment to summarize from hearings or roll calls. From the bill’s structure, the measure appears to be framed as a consumer-protection and transparency bill, with an emphasis on informing enrollees and holding carriers accountable for care restrictions tied to payment arrangements. The likely support would come from those favoring disclosure and patient protections, while opposition would likely focus on liability risk, administrative burden, and protection of reimbursement information.
The most likely points of contention are the new liability provision and the scope of mandatory disclosure. Health carriers and plan companies may object that the bill exposes them to lawsuits when reimbursement structures are alleged to contribute to delayed or denied care, and they may also resist requirements to disclose payment methodology details they consider commercially sensitive. Providers may have mixed views: some may support clearer contract terms and transparency, while others may be concerned about administrative complexity, compliance costs, and how the disclosures could affect contracting relationships. Another possible dispute is whether the bill’s language is broad enough to capture indirect incentives and whether causation in the new liability section is too expansive.